This announcement is a separate document:
中审众环会计师事务所关于灵康药业集团股份有限公司2023年年度报告的信息披露监管工作函的专项说明
Special instructions on the regulatory work letter of information disclosure about Lionco Pharmaceutical Group Co., Ltd.'s 2023 annual report from China Audit Crowd Environmental Accounting Firm.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated